Filing Details

Accession Number:
0001140361-13-046213
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-12-13 19:31:35
Reporting Period:
2013-12-11
Filing Date:
2013-12-13
Accepted Time:
2013-12-13 19:31:35
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
69499 Mylan Inc. MYL Pharmaceutical Preparations (2834) 251211621
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1197548 Harry Korman 1500 Corporate Drive
Canonsburg PA 15317
Chief Operating Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-12-11 24,898 $21.13 141,293 No 4 M Direct
Common Stock Disposition 2013-12-11 24,898 $41.75 116,395 No 4 S Direct
Common Stock Acquisiton 2013-12-11 15,288 $22.66 131,683 No 4 M Direct
Common Stock Disposition 2013-12-11 15,288 $41.84 116,395 No 4 S Direct
Common Stock Acquisiton 2013-12-11 9,814 $23.44 126,209 No 4 M Direct
Common Stock Disposition 2013-12-11 9,814 $41.94 116,395 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option Right to Buy Disposition 2013-12-11 24,898 $0.00 24,898 $21.13
Common Stock Stock Option Right to Buy Disposition 2013-12-11 15,288 $0.00 15,288 $22.66
Common Stock Stock Option Right to Buy Disposition 2013-12-11 9,814 $0.00 9,814 $23.44
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
4,732 2020-03-03 No 4 M Direct
7,644 2021-03-02 No 4 M Direct
48,016 2022-02-22 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,001 Indirect By 401(k) Plan
Footnotes
  1. Represents the weighted average price of the reporting person's disposition of 24,898 shares in transactions ranging from $41.51 to $42.48.
  2. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes 1, 3, and 4 to this Form 4.
  3. Represents the weighted average price of the reporting person's disposition of 15,288 shares in transactions ranging from $41.57 to $42.48.
  4. Represents the weighted average price of the reporting person's disposition of 9,814 shares in transactions ranging from $41.70 to $42.48.
  5. This option exercise and the related sale of the underlying common stock were executed pursuant to a 10b5-1 trading plan dated November 22, 2013.
  6. The options vested in three equal installments on March 3, 2011, 2012, and 2013.
  7. Two-thirds of the options vested in equal installments on March 2, 2012 and 2013. The remainder of the options will vest on March 2, 2014.
  8. One-third of the options vested on February 22, 2013. The remainder of the options will vest in equal installments on February 22, 2014 and 2015.